In practice

Risk of colistin resistance on the rise

  • B. Callens
  • F. Haesebrouck
  • J. Dewulf
  • F. Boyen
  • P. Butaye
  • B. Catry
  • P. Wattiau
  • E. De Graef


In a recent article from China, a transferable resistance mechanism has been described in Escherichia coli (E. coli), isolated from food-producing animals, meat and hospital patients (Liu et al., 2015). Recently, this resistance mechanism has also been found in Denmark, France, the United Kingdom and Belgium. Colistin is considered as one of the last resort treatments against multi-resistant bacteria in human medicine, especially for patients with cystic fibrosis. Alertness is needed and the new resistance mechanism has to be detected properly in animal and human related bacteria.

How to Cite:

Callens, B., Haesebrouck, F., Dewulf, J., Boyen, F., Butaye, P., Catry, B., Wattiau, P. & De Graef, E., (2016) “Risk of colistin resistance on the rise”, Vlaams Diergeneeskundig Tijdschrift 85(1), 36-40. doi:

Download PDF
View PDF



Published on
26 Feb 2016
Peer Reviewed